A randomised trial of custom-made compensators versus standard wedge compensators for breast radiotherapy
| ISRCTN | ISRCTN48733595 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN48733595 |
| Protocol serial number | Breast Dosimetry |
| Sponsor | Cancer Research UK (CRUK) (UK) |
| Funders | Cancer Research UK, Institute of Cancer Research, Royal Marsden Hospital , South East Thames Regional Health Authority |
- Submission date
- 15/10/2002
- Registration date
- 15/10/2002
- Last edited
- 08/04/2015
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Scientific
UKCCCR Register Co-ordinator
MRC Clinical Trials Unit
222 Euston Road
London
NW1 2DA
United Kingdom
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Scientific title | A randomised trial of custom-made compensators versus standard wedge compensators for breast radiotherapy |
| Study objectives | Not provided at time of registration |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Breast cancer |
| Intervention | 1. Radiotherapy with either custom-made compensators 2. Standard wedge compensators |
| Intervention type | Other |
| Primary outcome measure(s) |
Not provided at time of registration |
| Key secondary outcome measure(s) |
Not provided at time of registration |
| Completion date | 19/01/2000 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Not Specified |
| Sex | Female |
| Key inclusion criteria | 1. Early breast cancer (T1-3a N0-1 M0) 2. Histological confirmation of invasive carcinoma 3. Breast-preserving surgery 4. Higher than average risk of radiation normal tissue changes due to large breast size or irregular breast shape 5. Radiotherapy to the breast +/- lymphatics 6. No previous malignancy 7. Written informed consent |
| Key exclusion criteria | Not provided at time of registration |
| Date of first enrolment | 01/01/1997 |
| Date of final enrolment | 19/01/2000 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centre
MRC Clinical Trials Unit
London
NW1 2DA
United Kingdom
NW1 2DA
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | |
| IPD sharing plan |
